Member Info for Mulder

Nothing in those results to warrant such a butchery of the share price. $1.25Bn adjusted profit for Q3 $4Bn adjusted EBITDA remains on track. Debt down by $3.3Bn year on year. Still bearish greedy?

I had a good look at accounts and H1 results here before investing. I calculated adjusted EPS of $5.2 and EBITDA of $4Bn actually. Revenue and profits were well balanced across the portfolio. Intangibles/goodwill are high but no worse than GSK and AZN. Debt around 2x EBITDA should be fine. The market must have advanced dementia to worry about debt after 2 years have elapsed! Not much a PI can do if a company is lying though about results as you suggest. AbbVie clearly did not think they were when they bid for Shire!!

A dividend yield of 14% and a P/E of 3 would be great. Mike Ashley will have a lot of spare cash soon to buy out Debenhams...

Intrigued that you and others have been shorting this. FCA short position for Shire is <0.5% What made you short this? Is a P/E of 9 not low enough? Do you think the company has been lying about results and EPS forecasts? Leaks? Inside knowledge? The collapse in SP stinks and warrants a full investigation.

Just had another look at H1 results and the balance sheet. Revenue $895M vs $882M 2016 Up 1.5% Gross PROFIT $456M Vs $449M Up 1.6% Operating PROFIT H1 flat at $176M Balance Sheet Equity Ratio 2.26 [very good] Total equity $2.45Bn Vs $2.40Bn 2016 Cash at hand $244M Vs $247M 2016 Being supremely bearish and taking out all intangible assets and goodwill still gives shareholder equity of $1Bn NAV/Book price 1022p Price:Book value 1.1 So in summary I would say Hikma has a very solid balance sheet and far better than a company like GSK for example. Results were flat if not slightly better on the previous year. Hard to call a bottom here but we are trading not far off the book price which is rare. GSK trades at 15x book price. Dividend cover is 3x (!) - plenty of scope for a substantial increase.

I suspect the short selling hedge funds will not be on your Xmas card list! Shorting may still be legal for some reason but there is no doubt they manipulate the SP hammering it on any hint of bad news and suppressing any rise on good news. Again and again. Carillion has been my worst share this year like many I suspect but not much you can do when management suddenly reveal a �1Bn black hole!

Company stated EPS of $5/share just 3 months ago which puts shares on a P/E of just 9.2 after the collapse in SP. The market is clearly accusing them of lying about this.

IC View Investors who have had to stomach the 14 per cent share price fall since Mr Bucher took the helm may be able to take some comfort in management�s decision to maintain the dividend at 3.425p. **The retailer trades at a wider PE ratio discount to peers than its historic five-year average, implying further upside once the discount reverts. ***The shares also come with an attractive 7.4 per cent yield � that should keep investors satisfied until the recovery really kicks in. Buy Last IC View: Buy, 52p, 27 Jun 2017

Problem with AIM shares is the 'buy on rumour, sell on news' philosophy - happens all too often.

No the RNS says Monday 23rd October and disclosed 24th - so post-offer. (e) Date position held/dealing undertaken: 23/10/2017

To be frank it is an ABSOLUTE DISGRACE that this finished down today and did not rise at least 10%. I only have a small holding here but I know the shorters fully expected a cut in the dividend. LFL sales up, dividend maintained, debt down. A P/E of 7 is ludicrously low and a dividend of 7.4% in this case is because the SP is too low. Another example of short sellers placing a clamp on the SP preventing any rise but hammering it on any hint of bad news. Like I said, a complete disgrace and the FCA turn a blind eye. Just like the rise from 40p to 50p last month was highly suspicious on the back of no update or news - or perhaps these results and the maintained dividend news was leaked a month early??? Would not surprise me. Like I said - disgrace. SP should be AT LEAST 64p (P/E still only 10 and dividend a more sensible 5.3%)

I also understand if no deal is struck then Mediclinic can not return with an offer for several months according to takeover rules.

Shire hit 5036p here as recently as March. 30% fall in 6 months for a £35Bn 'blue chip'! US share hit $190 just in May. Now $139. Justified? ???

As we hit 4 YEAR lows this warrants a full FCA investigation if bad news does materialise as this has been going down every day for 3 months.

A deal has to happen here and a compromise reached for the sake of both sides. Whether Spire like it or not Mediclinic is the largest shareholder currently. Woodford 2nd. If Mediclinic walk away after all this the SP will fall and their own 30% stake devalues significantly. It would also sour relations between the two. Same goes for Spire if they refuse to strike a deal. Woodford needs this big time also. No one goes in with their highest offer. The Times said �1.3Bn which is 325p/share. Was surprised to see �1.2Bn Monday morning. 2nd offer should be around 330p IMHO. PS. Not sure why SP down today but did hit 304p yesterday.

LFL SALES UP DEBT DOWN EXCEPTIONALS DRAG PROFIT DOWN DIVIDEND YIELDING OVER 7% FINAL DIVIDEND ALONE YIELDS OVER 5% Should be trading over 60p IMO

https://www.drapersonline.com/news/debenhams-debuts-in-australia/7027025.article Debenhams has opened the doors to its first store in Australia. The 38,750 sq ft store in the St Collins Lane district in Melbourne, which spans two floors, is its first with franchise partner Pepkor. Debenhams outlined its plans to launch in Australia as part of a wider international expansion strategy last year.

Its US operations would surely make it harder to nationalise which is what Corbyn and the mad Oxford professor today suggested?

Looks like the drop today was due to the mad Oxford Professor and his report where he wants the Government to reduce green subsidies. Growing opposition across Europe to burning wood pellets also as apparently negligible reduction in pollution. However can they really afford to let Drax go bust? Article below highlights its importance to the UK economy and power supply. A lot of negative sentiment in the utility sector right now. It never rains but pours...

2014 was the last time this was seen in the 3500's. Credit Suisse issued a note today saying even in a worst case scenario these should be trading around 4500p so not sure what the market is playing at. Someone is loading up at these levels - could see an opportunistic bid. *********************************************************************************************************************************** Shire's current discount to its global sector peers is unjustified, even under a worst case scenario for haemophilia and hereditary angiodema, Credit Suisse argues. In a research report published on Wednesday, the analysts said the shares were then trading at a roughly 40% discount in terms of the price-to-earnings multiple, amid suggestions that so-called 'sell-side forecasts are "unrealistic". Yet even after revisiting its own estimates for Xidra, lowering its assumptions for the HAE franchise, assuming faster erosion from competition for Lialda and lowering its haemophilia numbers, it found that the shares should be trading 23% higher. https://www.digitallook.com/news/broker-recommendations/credit-suisse-slashes-shire-target-price-says-discount-to-peers-unjustified--2934095.html